Tech Company Inital Public Offerings

TransMedics IPO

Based in Andover, TransMedics is now a public company.

Transaction Overview

Company Name
Announced On
5/2/2019
Transaction Type
IPO
Amount
$91,200,000
Proceeds Purpose
Per the firm's most recent regulatory filing, it plans to use the net proceeds as follows: approximately $25.0 million to support commercialization of the OCS Lung and, if approved, the OCS Heart in the United States; approximately $20.0 million to fund research and development to design and manufacture the next generation of OCS technology; approximately $15.0 million for clinical trial expenditures, including those relating to our pre- and post-market clinical trials, including our TOP Registry, our OCS Liver PROTECT Trial and the use of the OCS Heart for DCD donor hearts; and the balance for working capital and other general corporate purposes.

Company Information

Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
200 Minuteman Rd. 302
Andover, MA 01810
USA
Email Address
Overview
TransMedics (Nasdaq: TMDX) has developed a revolutionary new system that enables living organ transplants.
Profile
TransMedics LinkedIn Company Profile
Social Media
TransMedics Company Twitter Account
Company News
TransMedics News
Facebook
TransMedics on Facebook
YouTube
TransMedics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Waleed Hassanein
  Waleed Hassanein LinkedIn Profile  Waleed Hassanein Twitter Account  Waleed Hassanein News  Waleed Hassanein on Facebook
Chief Financial Officer
Stephen Gordon
  Stephen Gordon LinkedIn Profile  Stephen Gordon Twitter Account  Stephen Gordon News  Stephen Gordon on Facebook
Chief Medical Officer
Tamer Khayal
  Tamer Khayal LinkedIn Profile  Tamer Khayal Twitter Account  Tamer Khayal News  Tamer Khayal on Facebook
Vice President
Jacqueline Sneve
  Jacqueline Sneve LinkedIn Profile  Jacqueline Sneve Twitter Account  Jacqueline Sneve News  Jacqueline Sneve on Facebook
VP - Engineering
John Sullivan
  John Sullivan LinkedIn Profile  John Sullivan Twitter Account  John Sullivan News  John Sullivan on Facebook
VP - Operations
John Carey
  John Carey LinkedIn Profile  John Carey Twitter Account  John Carey News  John Carey on Facebook
VP - Regulatory Affairs
Miriam Provost
  Miriam Provost LinkedIn Profile  Miriam Provost Twitter Account  Miriam Provost News  Miriam Provost on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/2/2019: Forto venture capital transaction
Next: 5/2/2019: TerraClear venture capital transaction

 

Share this article

 


About Database of VC Transactions

We document tech company VC transactions. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary